| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |